TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000262643 CCNE1 NA NA prostate cancer up-regulated predicted more...
ENST00000262643 CCNE1 NA NA cervical cancer up-regulated predicted more...
ENST00000262643 CCNE1 NA NA melanoma up-regulated predicted more...
ENST00000262643 CCNE1 NA NA colorectal cancer up-regulated predicted more...
ENST00000262643 CCNE1 NA NA papillary thyroid cancer up-regulated predicted more...
ENST00000262643 CCNE1 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000262643 CCNE1 NA NA pancreatic cancer up-regulated predicted more...
ENST00000262643 CCNE1 NA NA clear cell renal cell carcinoma up-regulated predicted more...
ENST00000262643 CCNE1 NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000262643 CCNE1 DB00675 Tamoxifen metastatic breast cancer up-regulated validated more...
ENST00000262643 CCNE1 DB16865 Rosmarinic acid pancreatic ductal adenocarcinoma down-regulated validated more...
ENST00000262643 CCNE1 (cyclin E ) NA Methoxychalcone prostate cancer down-regulated validated more...
ENST00000262643 CCNE1 DB12156 Cordycepin cervical cancer down-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3